Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Methicillin-Resistant Staphylococcus aureus | 25 | 2023 | 107 | 11.660 |
Why?
|
| Staphylococcal Infections | 27 | 2023 | 144 | 11.030 |
Why?
|
| Cross Infection | 24 | 2023 | 253 | 7.380 |
Why?
|
| Community-Acquired Infections | 13 | 2022 | 61 | 3.370 |
Why?
|
| Bacteremia | 11 | 2019 | 94 | 3.190 |
Why?
|
| Infection Control | 10 | 2023 | 149 | 2.610 |
Why?
|
| Genomics | 7 | 2022 | 53 | 1.750 |
Why?
|
| Staphylococcus aureus | 7 | 2023 | 63 | 1.470 |
Why?
|
| Sexual and Gender Minorities | 2 | 2021 | 23 | 1.400 |
Why?
|
| HIV Infections | 4 | 2013 | 457 | 1.110 |
Why?
|
| Catheterization, Central Venous | 3 | 2012 | 32 | 1.050 |
Why?
|
| Phenotype | 5 | 2021 | 292 | 1.030 |
Why?
|
| Humans | 44 | 2023 | 25692 | 1.020 |
Why?
|
| Chlorhexidine | 4 | 2021 | 52 | 1.000 |
Why?
|
| Methicillin Resistance | 4 | 2012 | 23 | 0.980 |
Why?
|
| Hospitals | 8 | 2023 | 143 | 0.720 |
Why?
|
| Critical Care | 2 | 2014 | 180 | 0.690 |
Why?
|
| Staphylococcal Skin Infections | 3 | 2011 | 8 | 0.670 |
Why?
|
| Risk Factors | 9 | 2020 | 2224 | 0.620 |
Why?
|
| Disease Outbreaks | 4 | 2023 | 75 | 0.610 |
Why?
|
| Hospital Administration | 5 | 2019 | 21 | 0.580 |
Why?
|
| Carrier State | 3 | 2013 | 47 | 0.570 |
Why?
|
| Anti-Infective Agents, Local | 3 | 2019 | 41 | 0.570 |
Why?
|
| Catheter-Related Infections | 2 | 2019 | 15 | 0.560 |
Why?
|
| Skin | 2 | 2014 | 99 | 0.530 |
Why?
|
| Anti-Bacterial Agents | 4 | 2021 | 333 | 0.520 |
Why?
|
| United States | 12 | 2023 | 1943 | 0.520 |
Why?
|
| Nose | 2 | 2013 | 27 | 0.490 |
Why?
|
| Pharynx | 1 | 2014 | 12 | 0.460 |
Why?
|
| Male | 13 | 2021 | 13917 | 0.460 |
Why?
|
| Nasal Cavity | 1 | 2014 | 30 | 0.460 |
Why?
|
| Chicago | 6 | 2020 | 869 | 0.460 |
Why?
|
| Quality Improvement | 3 | 2019 | 132 | 0.450 |
Why?
|
| Illinois | 3 | 2021 | 223 | 0.440 |
Why?
|
| Intensive Care Units | 5 | 2021 | 266 | 0.430 |
Why?
|
| Prisons | 1 | 2013 | 8 | 0.420 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 4 | 2015 | 30 | 0.420 |
Why?
|
| Soft Tissue Infections | 3 | 2011 | 22 | 0.400 |
Why?
|
| HIV | 1 | 2012 | 40 | 0.390 |
Why?
|
| Inservice Training | 3 | 2019 | 27 | 0.370 |
Why?
|
| Equipment Contamination | 3 | 2019 | 23 | 0.370 |
Why?
|
| Homosexuality, Male | 2 | 2021 | 26 | 0.360 |
Why?
|
| Medical Staff, Hospital | 1 | 2010 | 16 | 0.350 |
Why?
|
| Skin Care | 1 | 2010 | 9 | 0.350 |
Why?
|
| Prevalence | 3 | 2020 | 435 | 0.340 |
Why?
|
| Female | 11 | 2020 | 14273 | 0.340 |
Why?
|
| Teaching Materials | 2 | 2019 | 9 | 0.340 |
Why?
|
| Baths | 1 | 2009 | 21 | 0.330 |
Why?
|
| Health Personnel | 2 | 2021 | 102 | 0.320 |
Why?
|
| Adult | 11 | 2021 | 7336 | 0.320 |
Why?
|
| Molecular Epidemiology | 2 | 2021 | 27 | 0.320 |
Why?
|
| Phylogeny | 2 | 2021 | 42 | 0.310 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 4 | 2019 | 48 | 0.310 |
Why?
|
| Emergency Service, Hospital | 1 | 2010 | 245 | 0.280 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 143 | 0.280 |
Why?
|
| Prospective Studies | 4 | 2019 | 1633 | 0.280 |
Why?
|
| Genome, Bacterial | 2 | 2017 | 13 | 0.270 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 55 | 0.270 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2021 | 75 | 0.260 |
Why?
|
| DNA, Bacterial | 2 | 2017 | 39 | 0.260 |
Why?
|
| Hand Disinfection | 3 | 2019 | 22 | 0.250 |
Why?
|
| Middle Aged | 9 | 2019 | 8403 | 0.250 |
Why?
|
| Technology | 1 | 2023 | 5 | 0.220 |
Why?
|
| Arizona | 1 | 2023 | 6 | 0.220 |
Why?
|
| Health Facilities | 1 | 2023 | 22 | 0.210 |
Why?
|
| Poisson Distribution | 2 | 2015 | 21 | 0.210 |
Why?
|
| Personal Protective Equipment | 2 | 2019 | 13 | 0.210 |
Why?
|
| Incidence | 6 | 2011 | 731 | 0.210 |
Why?
|
| Communicable Diseases | 2 | 2023 | 21 | 0.210 |
Why?
|
| Program Development | 2 | 2019 | 59 | 0.200 |
Why?
|
| Methicillin | 1 | 2021 | 7 | 0.190 |
Why?
|
| Molecular Typing | 1 | 2021 | 9 | 0.190 |
Why?
|
| Community Networks | 1 | 2021 | 7 | 0.180 |
Why?
|
| Mupirocin | 1 | 2021 | 17 | 0.180 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 299 | 0.180 |
Why?
|
| Antimicrobial Stewardship | 2 | 2019 | 8 | 0.170 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2010 | 11 | 0.170 |
Why?
|
| Central Venous Catheters | 1 | 2019 | 2 | 0.170 |
Why?
|
| Formative Feedback | 1 | 2019 | 3 | 0.170 |
Why?
|
| Stakeholder Participation | 1 | 2019 | 9 | 0.170 |
Why?
|
| Disinfection | 1 | 2019 | 11 | 0.170 |
Why?
|
| Organizational Objectives | 1 | 2019 | 16 | 0.170 |
Why?
|
| Patient Isolation | 1 | 2019 | 18 | 0.170 |
Why?
|
| Aged | 6 | 2019 | 8501 | 0.170 |
Why?
|
| Health Care Surveys | 1 | 2019 | 59 | 0.160 |
Why?
|
| Academic Medical Centers | 2 | 2010 | 119 | 0.160 |
Why?
|
| Protective Clothing | 1 | 2019 | 8 | 0.160 |
Why?
|
| Patient Safety | 1 | 2019 | 49 | 0.160 |
Why?
|
| Medical Errors | 1 | 2019 | 25 | 0.160 |
Why?
|
| Research Personnel | 1 | 2018 | 18 | 0.150 |
Why?
|
| Curriculum | 1 | 2019 | 136 | 0.150 |
Why?
|
| Environmental Microbiology | 1 | 2017 | 5 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2018 | 57 | 0.150 |
Why?
|
| Bacteriological Techniques | 1 | 2017 | 17 | 0.150 |
Why?
|
| Specimen Handling | 1 | 2017 | 43 | 0.140 |
Why?
|
| Bacteria | 1 | 2017 | 72 | 0.140 |
Why?
|
| Risk Assessment | 1 | 2019 | 618 | 0.140 |
Why?
|
| Retrospective Studies | 3 | 2017 | 3220 | 0.130 |
Why?
|
| Physicians | 1 | 2018 | 112 | 0.130 |
Why?
|
| Health Services Research | 1 | 2016 | 38 | 0.130 |
Why?
|
| Urban Health Services | 1 | 2015 | 7 | 0.130 |
Why?
|
| Hospitals, Public | 1 | 2015 | 25 | 0.130 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 31 | 0.130 |
Why?
|
| Clostridium Infections | 2 | 2018 | 20 | 0.120 |
Why?
|
| Culture Media | 2 | 2017 | 29 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2015 | 115 | 0.120 |
Why?
|
| Genetic Markers | 1 | 2014 | 36 | 0.120 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 87 | 0.110 |
Why?
|
| Membrane Transport Proteins | 1 | 2014 | 51 | 0.110 |
Why?
|
| Comorbidity | 1 | 2015 | 457 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 74 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2015 | 329 | 0.110 |
Why?
|
| International Classification of Diseases | 2 | 2011 | 12 | 0.110 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 39 | 0.110 |
Why?
|
| Bacterial Load | 1 | 2013 | 9 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2010 | 3231 | 0.100 |
Why?
|
| Population Surveillance | 2 | 2010 | 103 | 0.100 |
Why?
|
| Regression Analysis | 1 | 2012 | 255 | 0.090 |
Why?
|
| Clinical Coding | 1 | 2011 | 4 | 0.090 |
Why?
|
| Genotype | 1 | 2012 | 326 | 0.090 |
Why?
|
| Bacteriuria | 1 | 2010 | 4 | 0.090 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2010 | 8 | 0.090 |
Why?
|
| Soaps | 1 | 2010 | 7 | 0.090 |
Why?
|
| Geography | 1 | 2010 | 12 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2010 | 39 | 0.090 |
Why?
|
| Gram-Positive Bacteria | 1 | 2009 | 9 | 0.080 |
Why?
|
| Blood | 1 | 2009 | 18 | 0.080 |
Why?
|
| Gram-Negative Bacteria | 1 | 2009 | 26 | 0.080 |
Why?
|
| Sentinel Surveillance | 1 | 2009 | 5 | 0.080 |
Why?
|
| Prognosis | 2 | 2010 | 739 | 0.080 |
Why?
|
| Data Collection | 1 | 2009 | 93 | 0.080 |
Why?
|
| Drug Administration Routes | 1 | 2008 | 8 | 0.080 |
Why?
|
| Hygiene | 1 | 2008 | 9 | 0.080 |
Why?
|
| Drainage | 1 | 2008 | 43 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 443 | 0.060 |
Why?
|
| Young Adult | 3 | 2019 | 1855 | 0.060 |
Why?
|
| Communicable Disease Control | 1 | 2023 | 10 | 0.060 |
Why?
|
| Quarantine | 1 | 2023 | 2 | 0.060 |
Why?
|
| Pandemics | 1 | 2023 | 227 | 0.050 |
Why?
|
| Competency-Based Education | 1 | 2019 | 14 | 0.040 |
Why?
|
| Child | 1 | 2023 | 1277 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2011 | 532 | 0.040 |
Why?
|
| Gloves, Protective | 1 | 2019 | 15 | 0.040 |
Why?
|
| Patient Discharge | 2 | 2010 | 136 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 57 | 0.040 |
Why?
|
| Family | 1 | 2019 | 94 | 0.040 |
Why?
|
| Training Support | 1 | 2018 | 5 | 0.040 |
Why?
|
| Career Choice | 1 | 2018 | 30 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 140 | 0.040 |
Why?
|
| Mentors | 1 | 2018 | 40 | 0.040 |
Why?
|
| Health Policy | 1 | 2018 | 42 | 0.040 |
Why?
|
| Universal Precautions | 1 | 2018 | 3 | 0.040 |
Why?
|
| Vancomycin-Resistant Enterococci | 1 | 2018 | 5 | 0.040 |
Why?
|
| Societies, Scientific | 1 | 2018 | 9 | 0.040 |
Why?
|
| Epidemiologists | 1 | 2017 | 1 | 0.040 |
Why?
|
| Resource Allocation | 1 | 2017 | 4 | 0.040 |
Why?
|
| Public Health Practice | 1 | 2017 | 7 | 0.040 |
Why?
|
| Public Health Administration | 1 | 2017 | 8 | 0.040 |
Why?
|
| Enterobacteriaceae | 1 | 2018 | 34 | 0.040 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2018 | 38 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 43 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2018 | 138 | 0.040 |
Why?
|
| Epidemiologic Methods | 1 | 2016 | 17 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2016 | 24 | 0.030 |
Why?
|
| Unnecessary Procedures | 1 | 2016 | 24 | 0.030 |
Why?
|
| Adolescent | 2 | 2011 | 2076 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 284 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 4459 | 0.020 |
Why?
|
| Virulence | 1 | 2011 | 8 | 0.020 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2011 | 7 | 0.020 |
Why?
|
| Utah | 1 | 2011 | 1 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 10 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 55 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2011 | 43 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 6 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 472 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 231 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2009 | 25 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 403 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2009 | 1781 | 0.010 |
Why?
|